Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mandelli

Showing results (561-570 of 573) with videos related to

Pageof 58
Sort By:
Haematologica|June 1, 1982
Long-term survival in adult acute leukemia. A multicenter study of 56 patientsS Tura, M Gobbi, M Cavo, et al.
Blood|August 15, 2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groupsM A Sanz, F Lo Coco, G Martín, et al.
Leukemia|August 30, 2002
Acute megakaryoblastic leukemia: experience of GIMEMA trialsL Pagano, A Pulsoni, M Vignetti, et al.
Haematologica|June 28, 2000
Hematopoietic stem cell transplantation in childhood: report from the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)A Pession, R Rondelli, P Paolucci, et al.
Bone Marrow Transplantation|April 20, 2004
Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantationA P Iori, R Cerretti, L De Felice, et al.
Haematologica|December 1, 1974
Splenectomy in early chronic myeloid leukaemia: preliminary report on 37 casesS Tura, M Baccarani, F Mandelli, et al.
Blood|August 1, 1997
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative GroupsF Mandelli, D Diverio, G Avvisati, et al.
Leukemia|February 19, 2013
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinibF Efficace, M Baccarani, M Breccia, et al.
Leukemia|May 3, 2016
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapyL Cicconi, M Divona, C Ciardi, et al.
Leukemia Research|June 30, 2015
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromesG Caocci, M T Voso, E Angelucci, et al.
Pageof 58

Showing results (561-570 of 573) with videos related to

Sort By:
Pageof 58
Haematologica|June 1, 1982
Long-term survival in adult acute leukemia. A multicenter study of 56 patientsS Tura, M Gobbi, M Cavo, et al.
Blood|August 15, 2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groupsM A Sanz, F Lo Coco, G Martín, et al.
Leukemia|August 30, 2002
Acute megakaryoblastic leukemia: experience of GIMEMA trialsL Pagano, A Pulsoni, M Vignetti, et al.
Haematologica|June 28, 2000
Hematopoietic stem cell transplantation in childhood: report from the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)A Pession, R Rondelli, P Paolucci, et al.
Bone Marrow Transplantation|April 20, 2004
Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantationA P Iori, R Cerretti, L De Felice, et al.
Haematologica|December 1, 1974
Splenectomy in early chronic myeloid leukaemia: preliminary report on 37 casesS Tura, M Baccarani, F Mandelli, et al.
Blood|August 1, 1997
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative GroupsF Mandelli, D Diverio, G Avvisati, et al.
Leukemia|February 19, 2013
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinibF Efficace, M Baccarani, M Breccia, et al.
Leukemia|May 3, 2016
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapyL Cicconi, M Divona, C Ciardi, et al.
Leukemia Research|June 30, 2015
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromesG Caocci, M T Voso, E Angelucci, et al.
Pageof 58